|
We typically read everything from Steven Davidoff Solomon, the bright law professor who writes the Deal Professor column in the New York Times DealBook. We frequently tweet his work. We usually like his thinking - but not this week.
A column on the Allergan-Valeant-Pershing Square (PS) situation (yes, again, sorry) accuses all sides of "being...too clever for their own good." He blames "an army of well-paid advisers" that is "consumed with outmaneuvering the other side" for losing "sight of what their ultimate goal is: the future of Allergan itself." We blame the entrenched, self-interested leadership at Allergan.
In a current blog post, we analyze how clever each side really is.
|
